Cancer is a disease that impacts us all

The University of South Australia (UniSA) is committed to tackling one of our most challenging diseases – Cancer – by establishing the largest cohort of cancer researchers ever assembled in South Australia.

With a focus on personalised precision treatments, better diagnostics, prevention and survivorship, the University has created a central cancer research hub housing over 300 leading biomedical, genetic and pharmacological cancer researchers in the new $247million UniSA Cancer Research Institute building on North Terrace.

This research, when combined with the work of UniSA research specialists in nanotechnology, radiobiology, drug engineering, psychology and allied health from UniSA’s three other campuses (Mawson Lakes, Magill and City East), creates a groundswell of expertise unsurpassed in the State.

Every day our experts are getting one-step closer to saving more lives as well as improving the quality of life for cancer survivors. But they need your help.

When you give today, 100% of your donation will go directly to the researchers - with no admin fees or hidden costs.

  Donate now   

Lifesaving new therapies for children with leukaemia

The research team led by Professor Shudong Wang at UniSA is a world-leader in developing effective and minimally toxic, targeted cancer therapies. They are currently fine-tuning a safer therapy for children with acute leukaemias to improve survival rates and reduce side effects.

“Our approach to creating better cancer therapies is to find and then target the specific genes or proteins that drive cancer cell development and growth,” says Professor Wang, Head of the Centre for Drug Discovery and Development.

"Our new targeted therapies will reduce the side-effects caused by chemotherapies to safeguard the developing minds and bodies of children with leukaemia."
Read more...

Professor Shudong Wang

New hope for brain cancer patients

"World-leading brain cancer researchers based at UniSA have developed new targeted drug therapies that could drastically improve treatment for lethal brain cancers, particularly glioblastoma.

"Glioblastoma is notoriously hard to treat with radiotherapy and chemotherapy. But the cancer also sends finger-like tendrils into vital brain structures, so surgery can usually only remove less than 90% of the tumour,” says Professor Stuart Pitson, Head of the Molecular Signalling Lab in the Centre for Cancer Biology.

"Our research has made an important advance for improving treatment for aggressive brain cancers."
Read more...

Professor Stuart Pitson

World-first discovery for better prostate cancer detection

A landmark discovery by UniSA researchers has led to the identification of 20 new prostate cancer biomarkers that will revolutionise how doctors diagnose the disease.

The researchers are the first to map an entire pathway of prostate cancer development. Critically, this knowledge will enable the research team to distinguish healthy prostate cells from prostate cancer cells to improve current tests.

“We expect this disruptive technology will transform prostate cancer detection and pathology assessment.”
Read more...


Professor Doug Brooks

Using gold nanoparticles to cripple cancer

Patent-pending gold nanoparticle technology under development is offering an exciting new approach to stop cancer in its tracks and revolutionise the way cancers are treated.

Led by Associate Professor Ivan Kempson from the Future Industries Institute at UniSA, the research has discovered a way to cripple a major DNA damage repair mechanism that cancers use to recover between doses of radiotherapy and chemotherapy.

“Our gold nanoparticles offer a radical new approach to stopping cancer in its tracks.”
Read more...


Associate Professor Ivan Kempson

Smart device to detect skin cancer

An innovative research team at UniSA has invented a game-changing device that any doctor will be able to use to quickly check a patient’s skin for suspected skin cancers.

Created by Professor Tarl Prow and his team, the micro-biopsy device takes a tiny pinprick sample from the skin that captures roughly 200 cells. It avoids the need for painful biopsies that require short anaesthetic surgery, stitches and often leave scars of 2-3cm in length.

“I want every GP to have one of these new skin cancer devices. They can click it on the skin and after a quick analysis, tell the patient if they have a skin cancer or not.”
Read more...

Dr Miko Yamada with Professor Tarl Prow

100% of your donation will make a difference

When you give to UniSA’s Fight Against Cancer Fund, every single dollar will fuel cancer research at UniSA, with no administration fees applied to your donation.

Contact us

If you’d like to know more about UniSA’s Fight Against Cancer Fund, please contact us using the form below:

Message goes here